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Abstract
Von Willebrand disease (vWD) is the most prevalent heredi-
tary bleeding disorder, affecting 0.6–1.3% of the population. 
While gastrointestinal bleeding from angiodysplasia is a 
well-known complication of vWD, the same is not true for 
Dieulafoy’s lesions (DLs). We report the case of a 21-year-old 
black male with type 1 vWD and 2 previous hospital admis-
sions for severe anemia with no visible blood loss. In both 
episodes, DLs were identified and treated endoscopically, 
one in the stomach and another in the duodenum. The pa-
tient presented to the emergency department in September 
2016 with dizziness, fatigue, and again no visible blood loss. 
He was hemodynamically stable, and laboratory workup 
showed a hemoglobin level of 3.4 g/dL. After transfusion of 
packed red blood cells, intravenous iron, and von Willebrand 
factor/factor VIII concentrate infusions, the patient under-
went upper endoscopy and colonoscopy, which were nor-
mal. Small-bowel capsule endoscopy showed dark blood 
and a fresh clot in the proximal jejunum. At this site, push 
enteroscopy identified a pulsatile vessel with an overlying 
minimal mucosal defect, consistent with a DL, type 2b of the 
Yano-Yamamoto classification, which was successfully treat-
ed with adrenaline and 2 hemoclips. The patient remains 
stable after 18 months of follow-up, with a hemoglobin level 
of 13.2 g/dL. This is a case of recurrent severe occult gastro-
intestinal bleeding from multiple DL in a young patient with 
vWD who is otherwise healthy. Three other cases of DL 
bleeding in the setting of vWD have been reported in the 
literature, suggesting a possible association between these 
2 entities. © 2018 Sociedade Portuguesa de Gastrenterologia 
Published by S. Karger AG, Basel
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Resumo
A doença de von Willebrand é a perturbação hemorrágica 
hereditária mais frequente, afetando 0.6 a 1.3% da popu-
lação. A hemorragia por angiectasias do tubo digestivo é 
uma complicação bem estabelecida desta doença. Con-
tudo, o mesmo não é verdade para as lesões de Dieulafoy. 
Apresentamos o caso de um doente de 21 anos, melano-
dérmico, com doença de von Willebrand tipo 1 e dois in-
ternamentos prévios por anemia grave sem perdas 
hemáticas visíveis. Em ambos os episódios foram identi-
ficadas lesões de Dieulafoy que foram tratadas endo-
scopicamente, uma das quais no estômago e outra no 
duodeno. O doente foi admitido no serviço de urgência 
em Setembro de 2016 por quadro de tonturas e cansaço, 
novamente sem perdas visíveis. Apresentava-se hemo-
dinamicamente estável e a avaliação laboratorial mostrou 
hemoglobina de 3.4 g/dL. Após transfusão de concentra-
dos eritrocitários, terapêutica com ferro endovenoso e 
concentrados de fator de von Willebrand/fator VIII, foram 
realizadas endoscopia digestiva alta e colonoscopia, sem 
alterações. A enteroscopia por cápsula detetou a presen-
ça de sangue digerido e um coágulo fresco no jejuno 
proximal. A enteroscopia de pulsão identificou nessa 
topografia uma solução de continuidade da mucosa mili-
métrica sobre lesão vascular pulsátil procidente, com-
patível com lesão de Dieulafoy tipo 2b da Classificação de 
Yano-Yamamoto, que foi tratada eficazmente com adre-
nalina e dois hemoclips. Após 18 meses, o doente man-
tém-se clinicamente estável e com Hb 13.2 g/dL. Este é 
um caso particular de hemorragia gastrointestinal oculta 
recorrente por múltiplas lesões de Dieulafoy num jovem 
com doença de von Willebrand, sem outras patologias. Há 
três casos semelhantes descritos na literatura, sugerindo 
uma possível associação entre estas duas entidades.
© 2018 Sociedade Portuguesa de Gastrenterologia
Publicado por S. Karger AG, Basel
Introduction
Von Willebrand disease (vWD) is the most prevalent 
hereditary bleeding disorder, affecting 0.6–1.3% of the 
population [1, 2]. It results from defects in von Wille-
brand factor (vWF), a multimeric glycoprotein that is es-
sential in platelet adhesion and aggregation and is also a 
carrier for coagulation factor VIII (FVIII). Type 1 vWD 
accounts for 70–80% of the cases and is characterized by 
a quantitative deficiency of vWF [3]. Type 2 vWD is 
caused by dysfunctional vWF, whereas type 3 vWD is 
characterized by the complete absence of vWF. Acquired 
forms of the disease are very rare and can be associated 
with a variety of conditions, including autoimmune dis-
eases, lymphoproliferative disorders, plasma-cell dyscra-
sias [4], and high shear stress conditions such as aortic 
stenosis [5].
The most common clinical manifestations of vWD in-
clude epistaxis, bruising, hematomas, and menorrhagia 
[3]. While gastrointestinal bleeding from angiodysplasia 
is a well-known complication of vWD [3, 6], the same is 
not true for Dieulafoy’s lesions (DLs). In fact, only 3 cas-
es of gastrointestinal bleeding from DLs in patients with 
vWD have been described so far [7–9]. 
Clinical Case
We present the case of a 21-year-old black male with severe 
type 1 vWD diagnosed in 2010, after an investigation of chronic 
iron deficiency anemia with a hemoglobin level of 10 g/dL. He had 
a history of recurrent bruising, occasional bleeding gums, 1 bleed-
ing episode after dental extraction, 2 episodes of severe epistaxis 
requiring nasal cauterization, and 2 hospital admissions (2009 and 
2014) due to severe anemia (hemoglobin reaching 3 g/dL) with no 
visible blood loss. In both of these episodes, DLs were identi- 
fied – 1 lesion in the lesser gastric curvature and 1 lesion in the sec-
ond part of the duodenum – and treated endoscopically, the first 
with argon-plasma coagulation and the second with adrenaline 
monotherapy. The patient was followed in the immunohemothera-
py outpatient clinic and was treated with oral and intravenous iron, 
when required. He was submitted to a trial of desmopressin treat-
ment, which was, however, suspended due to insufficient response.
In September 2016, the patient presented to the emergency de-
partment with fatigue and dizziness, with otherwise no signs of 
gastrointestinal bleeding. On physical examination, he was hemo-
dynamically stable, and his abdomen was soft and non-tender. 
Rectal examination showed no blood in the stool.
Laboratory workup showed a hemoglobin level of 3.4 g/dL, 
with a mean corpuscular volume of 67.1 fL and a mean corpuscu-
lar hemoglobin of 19.7 pg. The ferritin level was 5 ng/mL, and 
transferrin saturation was 7.3%. He had low vWF antigen (18.2%) 
and vWF ristocetin cofactor (16.2%) activity, with a normal FVIII 
(101%) concentration.
The patient received 5 units of packed red blood cells, intrave-
nous iron, and several vWF/FVIII concentrate infusions, with an 
adequate rise in hemoglobin to 7.3 g/dL.
Upper gastrointestinal endoscopy and colonoscopy were nor-
mal. Random biopsies of the gastric and duodenal mucosa re-
vealed no significant findings. Small-bowel capsule endoscopy 
identified, within a segment with dark blood in the proximal jeju-
num, a fresh clot apparently adhering to a mucosal fold (Fig. 1a, 
b). Push enteroscopy detected, in this location, a 3-mm mucosal 
defect over a protruding pulsatile vascular lesion, with no active 
bleeding (Fig. 2a). This was consistent with a DL, type 2b of the 
Yano-Yamamoto classification, which was treated endoscopically 
with an adrenalin injection (1: 10,000) combined with 2 hemostat-
ic clips (Fig. 2b, c). Endoscopic tattooing was performed both at 
the lesion level (Fig. 2d) and in the distal limit of progression.
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The patient was discharged after 4 days and experienced a 
steady increase in his hemoglobin level up to 13.2 g/dL, which is 
maintained after 18 months of follow-up. 
Discussion
A DL is a vascular abnormality corresponding to a di-
lated and tortuous submucosal artery that retains a large 
caliber as it reaches the mucosa [10]. It is an otherwise 
structurally normal vessel, with no associated atheroscle-
rosis or inflammation [11], and it is surrounded by histo-
logically normal mucosa [10]. It has been proposed that 
the pulsations of the artery disrupt the overlying epithe-
lium, ultimately resulting in erosion and bleeding [10, 
11]. Little is known, however, about the genesis of this 
malformation, and no direct disease associations have 
been clearly recognized. DLs are generally thought to be 
an acquired condition, mainly because they seem to be 
more common in the elderly. However, they can affect 
any age group and have even been reported in newborns 
[12], raising the possibility that they can also be congeni-
tal [11]. These lesions occur more frequently in males and 
in the setting of comorbidities such as cardiopulmonary 
dysfunction and chronic kidney disease. The use of aspi-
rin, warfarin, or nonsteroidal anti-inflammatory drugs 
has been reported in half of patients bleeding from DLs 
[13], although no causal link has been established. 
a b
Fig. 1. Images from small-bowel capsule 
endoscopy showing a segment with dark 
blood in the proximal jejunum (a) and a 




Fig. 2. Push enteroscopy images from the 
proximal jejunum showing a 3-mm muco-
sal defect over a protruding pulsatile vascu-
lar lesion, with no active bleeding; i.e., DL, 
type 2b of the Yano-Yamamoto classifica-
tion (a). The lesion was treated endoscopi-
cally with an adrenalin injection (1: 10,000) 
(b) combined with 2 hemostatic clips (c). 
Endoscopic tattooing was performed both 
at the lesion level (d) and in the distal limit 
of progression.
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Endoscopically, a DL is defined by the presence of either 
(1) arterial spurting or micropulsatile streaming, (2) a pro-
truding vessel, or (3) a fresh clot, associated with a normal 
surrounding mucosa or a minimal mucosal defect [11]. 
The large majority of DLs are found in the stomach, typi-
cally 6–10 cm from the gastroesophageal junction along 
the lesser gastric curvature [14]. Approximately one-third 
of all DLs are extragastric, most frequently located in the 
duodenum and colon [14]. Jejunal location was tradition-
ally considered very rare (< 1%) [11], but some recent re-
ports suggest that it may be more common than previous-
ly estimated, particularly the proximal jejunum [15]. DLs 
usually present as severe overt gastrointestinal bleeding, 
frequently with hemodynamic instability [16]. 
Endoscopic treatment is effective in around 90% of 
the cases, and evidence suggests that combined therapy 
should be preferred to monotherapy [13, 14, 16], with 
some studies favoring mechanical therapies such as band 
ligation or clipping to other methods [14].
We present a particular case of recurrent severe occult 
gastrointestinal bleeding from multiple DLs in a young 
patient with vWD who is otherwise healthy. This is a rare 
case in several aspects, including the recurrent nature, the 
jejunal location in the most recent episode, and particu-
larly the fact that the bleeding was repeatedly occult, al-
beit severe. The fact that a lesion could be identified 
through push enteroscopy without being actively bleed-
ing is also unusual, although the exploration was guided 
by the finding of a fresh clot in the same location by small-
bowel capsule endoscopy.
This case raises the question of whether there is a caus-
al association between vWD and bleeding from DLs. To 
date, 2 similar cases have been described in the literature, 
including a 72-year-old male with type 1 vWD and bleed-
ing duodenal DLs [7] and a 65-year-old male with a 
known history of type 2A vWD, liver cirrhosis, partial 
gastrectomy, and angiodysplasia, with bleeding gastric 
and duodenal DLs [9]. A third patient was reported with 
colonic DL and acquired vWD related to aortic stenosis 
[8].
It could be argued that vWD simply promotes bleed-
ing from a DL as it happens with other types of mucosal 
defects, without this necessarily implying a causal link or 
a shared pathophysiology. However, previous reports of 
similar cases and the severe and recurrent course of bleed-
ing in our patient evoke the possibility of a direct associa-
tion. Indeed, there is some evidence supporting a link be-
tween vWD and angiodysplasia [3, 6, 17], a different kind 
of vascular abnormality. These conditions were proposed 
to form a triad along with aortic stenosis in the patho-
physiology of Heyde’s syndrome, with the initial event 
being selective destruction of the largest vWF multimers 
by the stenosed aortic valve, resulting in acquired vWD 
[18, 19]. The loss of these multimers would then promote 
bleeding in the particular setting of a local high-shear 
condition found in angiodysplasias [18]. Whether a sim-
ilar mechanism could be involved in bleeding DLs in 
vWD is currently unknown. 
Another possible pathophysiological mechanism for 
this association could reside in the recently described an-
tiangiogenic properties of vWF [19]. Indeed, a recent 
study reported that the inhibition of vWF expression in 
endothelial cells in vitro resulted in increased angiogen-
esis mediated by vascular endothelial growth factor [20]. 
The same authors observed increased vascularization in 
vWF-deficient mice. In another study, vascular endothe-
lial growth factor expression was found to be increased in 
endothelial cells lining a DL [21]. A better understanding 
of this link between hemostasis and angiogenesis could 
have therapeutic implications in patients with vascular 
disorders. 
In conclusion, we report a clinical case that suggests a 
potential link between vWD and DL and propose possible 
pathophysiological mechanisms for this association, al-
though further investigation is needed to confirm this 
hypothesis.
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